Proliferating alveolar macrophages in BAL and lung function changes in interstitial lung disease.

In interstitial lung disease, the number of alveolar macrophages (AMs) can be increased. This may be caused by recruitment of precursor cells from peripheral blood and/or local proliferation in the lung. We therefore analysed proliferation, by studying both the expression of the nuclear proliferation antigen, Ki67, and the deoxyribonucleic acid (DNA) content, using the Feulgen reaction followed by cytometry. The patients had interstitial lung disease, i.e. sarcoidosis (n = 20), extrinsic allergic alveolitis (n = 20), idiopathic lung fibrosis or lung involvement in collagen-vascular disease (n = 19). In all patient groups there was a significant increase in proliferating AMs compared to healthy controls (4.2 versus 1.4% Feulgen, 2.1 versus 0.5% Ki67), with a significant correlation between these two parameters. A positive correlation was also found in bronchoalveolar lavage (BAL) between numbers of lymphocytes and proliferating cells in sarcoidosis and in fibrosis. In fibrosis, numbers of eosinophils and proliferating cells were also positively correlated. Our main finding was, however, a positive correlation between numbers of proliferating cells (Feulgen) and lung function parameters, especially vital capacity and oxygen tension (PO2) at rest, in patients with sarcoidosis and lung fibrosis. By contrast, in extrinsic allergic alveolitis, no correlation could be observed between proliferating cells and cell population or lung function. Our results suggest that local proliferation of macrophages is an important element in interstitial lung disease.

[1]  M. Elliott,et al.  The excess numbers of peritoneal macrophages in granulocyte-macrophage colony-stimulating factor transgenic mice are generated by local proliferation , 1992, The Journal of experimental medicine.

[2]  G. Firestein,et al.  Endobronchial allergen challenge in asthma. Demonstration of cellular source of granulocyte macrophage colony-stimulating factor by in situ hybridization. , 1991, The Journal of clinical investigation.

[3]  J. Hamilton,et al.  Cytokine regulation of colony-stimulating factor production in cultured human synovial fibroblasts: I. Induction of GM-CSF and G-CSF production by interleukin-1 and tumor necrosis factor. , 1990, Blood.

[4]  J. Gerdes,et al.  Proliferation, macrophage colony-stimulating factor, and macrophage colony-stimulating factor-receptor expression of alveolar macrophages in active sarcoidosis. , 1990, Laboratory investigation; a journal of technical methods and pathology.

[5]  P. Haslam,et al.  Increases in HLA-DQ, DP, DR, and transferrin receptors on alveolar macrophages in sarcoidosis and allergic alveolitis compared with fibrosing alveolitis. , 1990, Chest.

[6]  B. Chen,et al.  Role of granulocyte/macrophage colony-stimulating factor in the regulation of murine alveolar macrophage proliferation and differentiation. , 1988, Journal of immunology.

[7]  P. Capelli,et al.  Immunohistochemical analysis of sarcoid granulomas. Evaluation of Ki67+ and interleukin-1+ cells. , 1988, The American journal of pathology.

[8]  J. Larrick,et al.  Tumor necrosis factor production by human sarcoid alveolar macrophages. , 1986, The American journal of pathology.

[9]  Z. Cohn,et al.  The alveolar macrophage. , 1986, Journal of applied physiology.

[10]  R. Winchester,et al.  Characterization of mononuclear phagocyte subpopulations in the human lung by using monoclonal antibodies: changes in alveolar macrophage phenotype associated with pulmonary sarcoidosis. , 1985, Journal of immunology.

[11]  M. Laviolette,et al.  Abnormal bronchoalveolar lavage in asymptomatic dairy farmers. Study of lymphocytes. , 1984, The American review of respiratory disease.

[12]  V. Ferrans,et al.  Alveolar macrophage replication. One mechanism for the expansion of the mononuclear phagocyte population in the chronically inflamed lung. , 1984, The Journal of clinical investigation.

[13]  D. Mason,et al.  IMMUNOCYTOCHEMICAL DETECTION OF T AND B CELL POPULATIONS IN ROUTINE BLOOD SMEARS , 1984, The Lancet.

[14]  Hunninghake Gw Release of interleukin-1 by alveolar macrophages of patients with active pulmonary sarcoidosis. , 1984 .

[15]  Johannes Gerdes,et al.  Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation , 1983, International journal of cancer.

[16]  V. Ferrans,et al.  Inflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage. , 1979, The American journal of pathology.

[17]  Golde Dw,et al.  The pulmonary-alveolar macrophage (second of two parts). , 1979 .

[18]  R. van Furth,et al.  Origin, Kinetics, and characteristics of pulmonary macrophages in the normal steady state , 1979, The Journal of experimental medicine.

[19]  R. Furth,et al.  Origin, Kinetics, and characteristics of pulmonary macrophages in the normal steady state. , 1979 .

[20]  T. N. Finley,et al.  Proliferative Capacity of Human Alveolar Macrophage , 1974, Nature.

[21]  Y. Naum,et al.  Growth of Pulmonary Alveolar Macrophages in vitro , 1973, Nature.

[22]  H. Snoeck,et al.  Aberrant Ki-67 expression in normal bone marrow revealed by multiparameter flow cytometric analysis. , 1991, Cytometry.

[23]  G. Hunninghake Release of interleukin-1 by alveolar macrophages of patients with active pulmonary sarcoidosis. , 1984, The American review of respiratory disease.

[24]  D. Golde,et al.  The pulmonary-alveolar macrophage (second of two parts). , 1979, The New England journal of medicine.

[25]  M. Carl,et al.  Cytophotometric measurements of the DNA content of human malignant tumors by means of the Feulgen reaction. , 1966, Acta cytologica.